CLOs on the Move

Bellicum

www.bellicum.com

 
Bellicum Pharmaceuticals, located near the Houston Medical Center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. We are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT) and CAR T cell therapy. We are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.bellicum.com
  • 2130 West Holcombe Boulevard Suite 800
    Houston, TX USA 77030
  • Phone: 832.384.1100

Executives

Name Title Contact Details
Anavelys Ortiz-Suarez
Associate General Counsel Profile
Anavelys Ortiz--Suarez
Associate General Counsel Profile

Similar Companies

Marquez Process Service

Marquez Process Service is a Bellingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Microline Surgical

Microline Surgical develops and manufactures high precision open and laparoscopic surgical instruments. Microline`s laparoscopic reposable instruments provide a cost-effective and eco-friendly solution for today`s OR. The MiFusion product line offers a broad spectrum of open and laparoscopic instruments used to seal and divide tissue utilizing proprietary Thermal Fusion technology.

Advanced Care Scripts

Advanced Care Scripts is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Roche

606018 F. Hoffmann-La Roche AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

Shenzhen Hepalink Pharmaceutical Co.

Hepalink was established in 1998 and restructured in 2007 to be a limited liability company.